Trial intelligence / Profile preview

Verinurad + Allopurinol in Gout

NCT02498652Phase 2Completed

Sponsor
Ardea Biosciences, Inc.
Start
Jul 2015
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of verinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Jul 2015; status: completed.

02

Drugs

verinurad
03

Conditions

gout

Beyond the preview

Go deeper on NCT02498652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02498652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call